The University of Kansas Hospital Investigational Drug Services is a clinical research site located in Westwood, Kansas, United States 66205.
Crixeo Health Trust Score: 47/100 (POOR). This profile has not yet been claimed by the site owner.
The University of Kansas Hospital Investigational Drug Services has participated in 1 clinical trials.
Therapeutic areas: Relapsed/Refractory Diffuse Large B Cell Lymphoma, Relapsed/Refractory Primary Mediastinal B Cell Lymphoma, Relapsed/Refractory Transformed Follicular Lymphoma.
Sponsors: Kite, A Gilead Company.
Trust Score: 47/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
The University of Kansas Hospital Investigational Drug Services has a Crixeo Trust Score of 47/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
The University of Kansas Hospital Investigational Drug Services has 1 clinical trials on record. Their work covers Relapsed/Refractory Diffuse Large B Cell Lymphoma, Relapsed/Refractory Primary Mediastinal B Cell Lymphoma, Relapsed/Refractory Transformed Follicular Lymphoma.
The University of Kansas Hospital Investigational Drug Services has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.